Elanco has launched a new poultry tonic designed to support birds during the most demanding periods of productivity: during growth and peak laying.
The launch follows Elanco's acquisition of Janssen Animal Health and its existing poultry poultry tonic, which Elanco has improved.
Elanco Poultry Tonic HD Plus contains two new ingredients: a vitamin D3 metabolite and a natural antioxidant blend.
Elanco says the new product could prove just the tonic for the poultry industry in the face of rising fuel and feed costs. One study has apparently demonstrated as much as a 5:1 return on investment can be made as a result of supplementing the D3 metabolite alone.1According to the company, the vitamin D3 metabolite has been shown to increase egg weights (by around 2 per cent) and improve feed conversion and feed intake. It is more available to the body than vitamin D3, which plays a role in calcium metabolism (and therefore egg production). The benefits are significant for commercial egg producers but also for hatcheries, as egg size correlates with chick weight. Elanco says the metabolite can also improve bone strength, potentially resulting in healthier, more robust poults.The new antioxidant blend contains natural preparations of vitamins as well as more complex antioxidants found in fruits and vegetables, such as flavanoids, polyphenols and carotenoids. It also contains nucleotides and sulphur containing amino acids, methionine and lysine. Elanco's new Poultry Tonic HD Plus is suitable for layers, broilers, breeders and turkeys and is available from veterinary wholesalers and animal health distributors. The company is also launching Game Bird Tonic HD Plus at the same time.
Reference
1. SOTO-SALANOVA MF MOLINERO A, Efficacy of the use of Hy-D® in laying hens, XI th European Symposium on the Quality of Eggs and Egg Products 191 Doorwerth, The Netherlands, 23-26 May 2005
According to the survey, 64% of veterinary surgeons now see Brexit as more of a threat than an opportunity for the UK veterinary profession, compared to just half in autumn 2016. Conversely, the number that see Brexit as being more of an opportunity has dropped from 18% to 14% over the same period.
Vets working in academia and industry were the most gloomy: 69% of vets in academia and 58% of vets in industry see Brexit as more of a threat to their own area of work than an opportunity.
The biggest impact appears to have been on veterinary recruitment, with 53% saying Brexit has made it harder to recruit veterinary surgeons, compared to only 18% in 2016. By comparison, only 11% said it has become harder to recruit veterinary nurses.
51% also now consider Brexit as a threat to animal welfare, compared to 43% in 2016.
BVA President Simon Doherty (pictured right, looking decidedly chipper despite it all) said: "As the UK Government ramps up its planning for a no-deal scenario, it’s clear that the veterinary profession is becoming increasingly concerned about the potential impact of Brexit.
"Top of vets’ list of concerns is significant veterinary workforce shortages across critical areas of animal welfare and public health. Veterinary concerns around animal welfare have also increased as the Government continues to stall on introducing new legislation to enshrine animal sentience in UK law before March.
"From pet passports and food safety, to disease surveillance and trade certification, there is no area of veterinary work that is not touched by Brexit. So, we can fully understand why our members are worried about the future. BVA will continue to raise these important veterinary issues with policymakers to ensure the profession is considered as Brexit discussions continue."
The BVA briefings on “Brexit and the veterinary profession” and “No deal Brexit and the veterinary profession” set out all of the issues of interest in more detail.
A group of brave veterinary nurses and a student nurse leapt out of a perfectly serviceable aircraft last weekend, both to raise money for children with epilepsy, and to highlight the need to protect the title 'Veterinary Nurse' in law.
Vicky Couzens, Jenny Cook, Kim Blowing, Michelle Dickens, Gillian James and Leigh Martin, none of whom had parachuted before (in fact, Gillian hadn't even been in a plane before), were raising money for the Muir Maxwell Trust, a charity which funds research into childhood epilepsy, and supports the families of some of the 70,000 children affected by it in the UK.
The daredevil nurses also wanted to highlight the fact that anyone can call themselves a veterinary nurse, regardless of whether they've ever even set foot inside a veterinary practice, let alone passed the demanding examinations. They argue that the title 'Veterinary Nurse' should be protected in law, in exactly the same way as 'Veterinary Surgeon', so that the pet-owning public can have the reassurance of knowing when their animal is being cared for by a qualified professional.
To support these nurses' efforts, and help them reach their fundraising targets, click the links below:
http://www.justgiving.com/Victoria-Couzens http://www.justgiving.com/Jenny-Cook23 http://www.justgiving.com/KimBlowing http://www.justgiving.com/Michelle-Dickens
Meanwhile, one of the children that has benefitted from the work done by the Muir Maxwell Trust is Emily Guthrie, daughter of the editor of VetNurse.co.uk and VetSurgeon.org. She sent the jumpers her own message of thanks:
The company says it has made the test available in response to customer demand and growing evidence that in rare cases pets living with COVID-19-positive humans can be at risk of infection.
The test will be available to veterinary surgeons in North America this week and will roll out across most of the world in the coming weeks, via the company's worldwide network of laboratories.
Jay Mazelsky, President and Chief Executive Officer of Idexx Laboratories said: "We have continued to monitor the rapidly evolving public health crisis worldwide, paying special attention to the effects on pets.
"While there is currently no evidence that dogs or cats play a role in transmitting the disease to humans, it became clear offering the test was the right thing to do when we saw clinical evidence that pets—especially cats and ferrets—can in rare cases be at risk for infection. And, we heard from our customers around the globe that veterinarians needed a testing option."
Idexx recommends the test is used when three specific criteria are met:
Idexx says leading health authorities agree with the company that transmission of the SARS-CoV-2 virus is primarily person-to-person and advise against testing asymptomatic pets. Since mid-February, the company has tested over 5,000 specimens for the virus, from cats, dogs, and horses with respiratory symptoms in 17 countries. To date, it has found no positive results, suggesting that dogs and cats living with infected people generally remain uninfected, except in rare and isolated cases.
For information about the Idexx SARS-CoV-2 (COVID-19) RealPCR Test for pets, visit idexx.com/covid19-pet-test.
VetUK, an online supplier of pet products and veterinary prescription only medications, has announced that it now processes over £750,000 worth of online transactions per month.
The point of the press release was to highlight that this has been achieved using paypoint.net to handle the tens of thousands of orders that VetUK says it receives each month, and process the payments.
However, it does also highlight the ever growing competition to veterinary practices from online. You might like to check VetUK's POM prices here.
Tim Harrison, managing director at White Cross Vets, said: "Our plan has been to open five new practices within a 12 month period and despite having a strong presence in West Yorkshire we didn’t have a practice in South Yorkshire. When we found out Dave wanted to move to Sheffield it made perfect sense for us to expand into the area and for him to lead the practice as clinic director.
"Dave is a hugely talented and compassionate professional and we certainly didn’t want to lose him. The Handsworth opening is the perfect fit for Dave who will lead a team of four. As the practice expands, we envisage that we will create a further 20 jobs over the next five years.”
White Cross says it has invested £250,000 in the practice, which is opening on the site of a former sausage factory which has recently been redeveloped at a cost of £1.1M.
Dave said: "I was so thrilled when Tim told me his plans for Sheffield. I love the area and my wife’s family have grown up there, I have been wanting to set up a long term family home for a while, and the fact that I have been able to move my young family to South Yorkshire, and still work for White Cross Vets, makes me really happy."
Dechra says phenobarbital is effective as a monotherapy in 60 to 80 per cent of dogs with idiopathic epilepsy, but that in 40% of dogs, seizures cannot be controlled with phenobarbital alone. In these cases the company's potassium bromide treatment Libromide, is licensed to be used alongside Soliphen as a concurrent therapy.
According to the company, the combination of phenobarbital and potassium bromide has been shown to reduce seizure number and severity in dogs with refractory idiopathic epilepsy; in tests, the combination treatment reduced the mean seizure rate from 27.4 seizures per month to 2.2 seizures.
Dechra Veterinary Products Brand Manager Craig Sankey said: "Epilepsy is the most common chronic canine neurological disorder, affecting around 0.62 per cent of dogs.
"It can be a distressing condition for both the animal and its owner so we are launching a therapy that can reduce the number of seizures in even the most challenging cases.
"We have also produced new guidelines for prescribing vets, detailing step by step how the treatments can act alone or concurrently. We believe using Soliphen as a sole therapy or in conjunction with Libromide will make a positive contribution to veterinary professionals in their ongoing treatment and management of dogs with epilepsy."
For more information, visit www.dechra.co.uk
The award, which is sponsored by Zoetis, is for early-career vets who have gone above and beyond the usual call of duty or who are making a difference within their community or the veterinary profession. Fabian was picked out of three finalists at a virtual award ceremony last night.
The judges said he'd wowed them with his ongoing proactive contributions to the veterinary profession and his passion for raising awareness around exotic animal care.
Fabian is a practising vet and the latest member of the team on CBBC children’s TV show, ‘The Pets Factor’. He is also a recent graduate member of BVA Council.
In his spare time, he is an active writer. Whilst attending the University of Veterinary and Pharmaceutical Sciences in Brno, which he graduated from in 2018, he wrote his own student blog, ‘Dready Vet’. Since then, he has published several articles on a variety of topical and important issues such as ethnicity and race, diversity within the profession, feminism, Halal slaughter and reptile health and welfare.
The judges credited Fabian for his passion for communicating the complex welfare needs of non-traditional companion animals to the public.
Fabian said: "First of all I’d like to pay tribute to Nat and Ben and all the nominees. They are really important to where the veterinary profession goes in the future and I’m indebted to them for what they’ve been able to do in a short period of time. They are an inspiration to me.
"Thank you to the judges. It’s really important that we start to celebrate each other and celebrate our wins. This is something I’ve tried hard to do this year.
"Thank you to everyone who’s supported me and been part of this journey. It means a huge amount.”
BVA President James Russell said: "Fabian has made a significant impact within the profession and beyond. The broad reach of his work – on issues that affect our profession and animal welfare – has made a national impact and promoted our profession to new audiences of all ages.
"During a particularly challenging year for all of us, Fabian has shown immense leadership and he is a truly deserving winner of the BVA Young Vet Award 2020."
The company conducted the survey of 404 owners after news that the bio-pharma company Okava plans to trial a weight-loss drug for dogs that mimics the effects of weight-loss drugs like Wegovy, tapping into a potential $10 billion market.
Of the pet owners who responded, it was the younger group aged 25-34 who were most receptive to the idea of a weight-loss drug for their pet (56%).
That figure fell to 21% of 45–54-year-olds and 20% among those aged 55 and above, most of whom were probably holding up their hands in horror: "Whatever next".
Alicia Hempsted, pet insurance spokeswoman from MoneySuperMarket, said: “If GLP-1 style treatments for obesity become available for dogs in the future, it’s likely that owners will have to pay out of pocket for them, which may affect their availability."
https://www.moneysupermarket.com/pet-insurance/
Photo: www.depositphotos.com
The researchers say that ultimately the study should help with the development of guidelines to help all riders assess if they are the right weight for the horse or pony they intend to ride, to enhance both equine welfare and rider comfort and enjoyment.1
Dr Sue Dyson, Head of Clinical Orthopaedics at the Animal Health Trust’s Centre for Equine Studies, Newmarket, who led the study said: "While all the horses finished the study moving as well as when they started, the results showed a substantial temporary effect of rider weight as a proportion of horse weight.
"The results do not mean that heavy riders should not ride but suggest that if they do they should ride a horse of appropriate size and fitness, with a saddle that is correctly fitted for both horse and rider.
"We must remember that this is a pilot study: further work is required to determine if horse fitness, adaptation to heavier weights and more ideal saddle fit will increase the weight an individual horse can carry. This should help us further in our quest to develop guidelines for optimum rider: horse bodyweight ratios."
As the average weight and height of humans continues to increase there is growing debate about relative rider-horse sizes, with riding school horses epitomising the variety of weights of rider that a single horse may be exposed to.
Numerous inter-related aspects are involved with the horse and rider combination including the age of the horse, its fitness and muscle development, the length of its back and the presence or absence of lameness. The rider’s skill, fitness, balance and coordination are important factors, as is the fit of the saddle to both the horse and rider. The type, speed and duration of work and the terrain over which the horse is ridden must also be considered.2
To date little research has been conducted on the effects of rider weight on equine welfare and performance. To address the shortfall World Horse Welfare, the Saddle Research Trust, the British Equestrian Federation and a number of other organisations helped to fund a pilot study last summer, the results of which have now been analysed.
The influence of rider to horse bodyweight ratios on equine gait and behaviour: a pilot study1 assessed gait and behavioural responses in six horses ridden by four riders of similar ability but different sizes. The riders were all weighed in their riding kit and were subsequently categorised as being light, moderate, heavy and very heavy. Their body mass index (BMI) was also calculated.
Each rider rode each horse in its usual tack and performed a set pattern of exercises comprising mainly trot and canter. Gait, horse behaviour, forces under the saddle, the response to palpation of the back, alterations in back dimensions in response to exercise, heart and respiratory rates, salivary cortisol levels and blink rate were assessed for each combination.
The riding tests for the heavy and very heavy riders were all abandoned, predominantly because of temporary horse lameness. This was likely to have been induced by bodyweight rather than BMI, given that the heavy and moderate riders had similar BMIs, both being classified as overweight, yet only one of the moderate rider’s tests had to be abandoned. An ethogram, developed by Dr Dyson specifically to assess behavioural markers which may reflect pain in ridden horses3, was applied. The scores which may reflect pain were significantly higher in the horses when ridden by the heavy and very heavy riders.
The study also raised the issue of rider height and saddle fit. The owner of one of the test horses had a similar bodyweight: horse bodyweight ratio to the heavy rider and was of similar weight, but significantly different in height (157.0 and 185.5 cm, respectively). This large difference in height has major potential implications for saddle fit for the rider and consequently the rider’s position and weight distribution. The taller rider sat on the back of the cantle, overloading the back of the saddle and making it more difficult to ride in balance, with the heel being in front of a vertical line between the shoulder and ‘hip’.
Roly Owers, Chief Executive of World Horse Welfare, said: "These pilot results are certainly not surprising but are very significant in adding vital evidence to inform an appropriate rider: horse weight ratio. It is common sense that rider weight impacts equine welfare however many might not fully understand or recognise this. What is desperately needed is basic guidance to help riders identify a horse or pony that is right for them and this research is a vital step in that direction.”
The study was generously supported by World Horse Welfare, the Saddle Research Trust, Frank Dyson, British Equestrian Federation, British Horse Society, Pony Club, Polocross, The Showing Council, The Showing Register, The Society of Master Saddlers, Riding for the Disabled, British Eventing, British Dressage, the British Horse Foundation, the Worshipful Company of Saddlers and Endurance GB.
References
Nutrafibre contains high fibre pellets which use a combination of insoluble and soluble plant fibres, probiotic & prebiotics and fish hydrolysate which, the company says, optimises stool consistency and encourages normal bowel movements.
The company claims Nutrafibre also assists anal gland clearance, helps maintain a sufficient level of fibre in the body, supports pets with sensitive digestion, helps reduce hairball in cats and also helps to balance raw and high meat content diets.
Chris Jones, Director at Nutravet said: “We’re incredibly excited to launch this innovative new fibre product.
"The team have worked in partnership with veterinary practices across the UK to create this high fibre supplement and the feedback has been incredibly positive from both vets and pet owners alike.”
For more information, contact: 0845 604 1688, email: info@nutravet.co.uk or visit www.nutravet.com.
Elle says she created the course she wished she had when she first qualified, one which offers provides practical tools and tailored support to build confidence, overcome self-doubt, and thrive in veterinary practice.
She said: “I remember what it felt like to step into practice as a newly qualified vet nurse—feeling unsure, overwhelmed, and constantly questioning whether I was good enough.
"That’s why I created this course - to give vet professionals the support and confidence they deserve.”
The Confidence Coaching CPD Course includes:
Elle says the course is ideal for both vets and vet nurses, in particular those struggling with confidence in their clinical skills, and professionals looking to progress in their careers.
The course costs £350, but as part of the launch, Elle is offering a 25% limited-time discount for those who sign up early using the code: PVN25.
https://thepositivevetnurse.com/cpd-course
The £35 course is aimed at veterinary surgeons, veterinary nurses, receptionists and practice managers who may be faced with difficult and sensitive conversations around pet loss with clients. It covers:
Empathy vs sympathy
Communicating with active listening skills
Open questions
Face-to-face emotional support, telephone support, email support and other written communication
The Blue Cross says that the new course complements its £280, eight-week 'Pet Bereavement Support' course for more in-depth training, and also its hourly webinars, which cost £20.
The eight-week course requires a minimum of three to four hours of study per week and counts towards 32 hours Continual Professional Development.
For specific needs, the Blue Cross can also work with practices to provide bespoke face-to-face training across the UK, specifically tailored and delivered at the practice.
For more information, visit www.bluecross.org.uk/pbss-course or call 01993 867216.
The association has also compiled free access special collection on backyard poultry in the BSAVA library which is available until the end of December 2019.
The BSAVA's Q&As on avian influenza in backyard poultry are:
What is avian influenza?Avian influenza (AI) is highly contagious viral disease that affects both domestic and wild birds. AI viruses are usually classified into two categories: low pathogenicity avian influenza (LPAI), which typically causes no or very few clinical signs in poultry, and high pathogenicity avian influenza (HPAI) which typically causes high mortality rates in poultry1.
What are the clinical signs of disease in poultry?The type and severity of clinical signs displayed will be dependent upon the strain of the virus and the species affected; some species such as ducks and geese may show few clinical signs2.
How is the disease spread?Wild bird species are the natural host and reservoir for all types of avian influenza, naturally carrying the virus in their respiratory and intestinal tracts, commonly without developing signs of the disease1,3. The virus is predominantly spread via body secretions, both directly and indirectly2. Migratory birds (predominantly waterfowl and gulls) can spread the disease over a wide geographical area3.
Why is the winter a higher risk period for avian influenza? The UK is at increased risk of avian influenza from migrating birds during winter2. Furthermore, avian influenza viruses are able to survive for prolonged periods of time in the environment, particularly in low temperatures4.
How can I prevent my birds from contracting avian influenza?All keepers of poultry should ensure that they uphold good levels of biosecurity to prevent disease entering their flock. This includes:
maintaining good levels of hygiene and regularly disinfecting hard surfaces;
changing shoes before entering/leaving to avoid transferring faeces in/out of the poultry enclosure;
minimizing contact with wildlife by humanely controlling rodents and deterring wild birds. Contact with wild birds can be minimized by placing food and water in an enclosed area such as the coop, and preventing poultry from accessing ponds/standing water frequented by wild bird populations, for example by erecting temporary fencing;
where possible, keeping birds of different poultry species separate (e.g. ducks and geese should be separate from chickens).
Whilst it is important that all backyard keepers maintain good levels of biosecurity, it is particularly prudent for keepers in areas deemed at higher risk of an incursion of avian influenza. In Great Britain, a number of High Risk Areas (HRAs) have been identified based upon previous experience, scientific expertise and veterinary opinion, and are predominantly areas where large numbers of migratory wild birds gather. To find out whether you are in a HRA, use the interactive map.
What should I do if I suspect avian influenza?Avian influenza is a notifiable disease. If it is suspected, it must be reported immediately:
In England, contact the Defra Rural Services Helpline on 03000 200 301
In Wales, contact your local Animal and Plant Health Agency (APHA) office on 0300 303 8268
In Scotland, contact your local Field Services Office
For keepers in Northern Ireland, contact your local DVO.
Evidence-Based Veterinary Medicine Matters: Our Commitment to the Future represents the first time that such a broad and influential group has united in support of a single issue in the veterinary profession.
The publication contains a number of case studies which illustrate the impact that evidence can have – and has had – on animal health and welfare. It also provides a rationale for veterinary professionals to contribute to the evidence base and put evidence into practice, to the benefit of animals, owners and veterinary teams themselves.
The signatories to the commitment are:
Animal and Plant Health Agency
British Cattle Veterinary Association
British Equine Veterinary Association
British Small Animal Veterinary Association
British Veterinary Association
British Veterinary Nursing Association
RCVS Knowledge
Royal College of Veterinary Surgeons (RCVS)
Royal Veterinary College
University of Bristol
University of Cambridge
University of Liverpool
University of Nottingham
University of Surrey
Veterinary Policy Research Foundation
No sign of the BAHVS, I see.
Jacqui Molyneux, Chair of the Board of Trustees of RCVS Knowledge, said: "Evidence-Based Veterinary Medicine Matters is a milestone publication for the professions, representing the first time the majority of the key institutions have aligned under the same EBVM banner.
"A celebration of decades of incredible discoveries, achievements and improvements in animal health, it also serves to remind us that even the earliest forms of veterinary medicine were underpinned by evidence."
UK Chief Vet Christine Middlemiss said: "What’s the evidence? An evidence-based approach is vital in all areas of our profession, whatever is keeping you awake at night. For me, it is the threat of African swine fever and avian flu. The evidence I rely on comes from our specialist surveillance monitoring and testing, veterinary epidemiologists and disease modellers. It enables me to make timely, proportionate risk-based decisions that stand up to scrutiny.
"If you are managing veterinary care in practice, the evidence you rely on to underpin your standards of clinical care comes from multiple sources too. Evidence-based veterinary medicine allows us to refine and tailor strategies to be effective and efficient, making full use of existing and new technologies.
"The profession has taken great strides towards embracing evidence-based veterinary medicine and building on this will strengthen the links between clinical decision-making, policy development and future research."
Chris Gush, Executive Director of RCVS Knowledge, added: "We are impressed by the contributions from our co-signatories, which clearly demonstrate the phenomenal impact on patient outcomes that conducting research and using evidence can have. We are also delighted that Sense about Science, a flagbearer for evidence, transparency and rational thinking, has joined with us to highlight the many benefits EBVM can bring.
"The publication also makes a strong case for much-needed funding for research to grow the evidence base, which would put powerful, robust data into the hands of veterinary professionals as they make critical decisions that can affect patient outcomes.
"It is our hope that the calibre, diversity and sheer number of the organisations putting their name to this commitment will galvanise all vets and their teams to expand their use of evidence in practice."
Rebecca Asher, Deputy Director at Sense about Science, said: "This is a showcase of game changers in veterinary care and we hope it will inspire and motivate everyone in the profession.
"We were delighted that RCVS Knowledge approached us to collaborate with them and other leading institutions in the veterinary research community to affirm their commitment to an evidence-based approach to veterinary medicine.
"Everyone expects treatment for humans to be underpinned by evidence. We now expect the same of the whole veterinary community when it comes to the treatment of animals."
The full commitment and portfolio of case studies can be read in Evidence-Based Veterinary Medicine Matters, available for free online: bit.ly/EBVMMatters.
The new editorial team of Ed Hall, David Williams and Aarti Kathrani says the manual has been completely rewritten and reorganised to provide a current, well-structured overview of the main gastrointestinal diseases that challenge both clinical practitioners and academics.
The Manual is divided into four sections:
Diagnostic procedures and techniques: history taking, physical examination, clinical pathology, imaging and biopsy.
Diagnostic approaches to problems: diagnostic approach to complaints/problems affecting the GI tract, pancreas and liver.
Patient management: treatments available for GI, pancreatic and liver disease, including a chapter on fluid and nutritional therapy.
Diseases of specific systems/organs: conditions of organs of the GI tract, including pathophysiology, clinical signs, diagnosis, treatment and prognosis.
Ed Hall said: "The busy small animal practitioner is likely to see a dog or cat with GI signs most days and having this Manual as a resource should give them greater insight into the conditions they are treating and hopefully make their job more satisfying."
The BSAVA Manual of Canine and Feline Gastroenterology is available in a printed edition (£90; £60 to BSAVA members) and an online edition (£75 +VAT; £50 +VAT to BSAVA members).
In a European first, Pfizer Animal Health is conducting a major study in over 2000 dogs with Trocoxil, its new NSAID which delivers continuous analgesia for a month.
According to the company, Trocoxil has already been granted a licence by the EMEA and pre-authorization studies have already shown once-monthly Trocoxil to be at least as safe and effective as daily carprofen. However, the monthly dosing regimen represents such a big step from the currently used approach of daily NSAID dosing, that Pfizer has decided to initiate the study before launching the product in order to closely monitor and manage the introduction of Trocoxil to the veterinary market.
Jolian Howell, Associate Director Companion Animal Marketing for Pfizer said: "A drug with such a unique dosing regimen should be introduced in a controlled and managed way, and this study is part of that commitment by Pfizer Animal Health."
This large post-approval study, conducted under veterinary control as a User Experience Study, will enable a similar comparison with carprofen to be made in a much larger patient population. In fact it will be sufficiently large to provide product-specific safety information, such as any differences in the incidence of side-effects.
The randomised, parallel group study is being conducted in more than 100 veterinary clinics throughout France, Germany and the UK. Each dog will receive up to 6 months of treatment during which time it will be assessed every month by the veterinary surgeon.
Trocoxil, a preferential COX-2 inhibitor, has a unique pharmacological profile which means that a single oral dose provides continuous pain relief for a whole month.
Jolian added: "This study will provide veterinary surgeons with an opportunity to experience the benefits of using Trocoxil to treat OA continuously over a period of months. It will also give them the opportunity to assess the benefits this offers the owner."
During the week, veterinary professionals, retailers and rabbit owners will be encouraged by Burgess and campaign partners the RSPCA, RAWF, Wood Green, PDSA and Blue Cross to sign and share a pledge to move away from muesli on the website: http://www.rabbitawarenessweek.co.uk.
Alex Thorne at Burgess Pet Care, said: "Muesli should never be part of a rabbit’s diet but, sadly, a widespread lack of understanding and awareness around its risks means it’s often too easy for rabbit owners to make the wrong choice. Research continues to show that there is a lack of understanding around the correct nutritional needs of rabbits, and the continued feeding of muesli is a major outcome of that.
"Feeding rabbits muesli increases the risk of selective feeding. Just like children would typically pick sweet treats when faced with the choice between them or vegetables, rabbits will eat parts of the muesli mix that are high in starch and sugar, whilst leaving behind the more nutritious elements.
"We’re encouraging all rabbit lovers to get involved with this year’s campaign by visiting the Rabbit Awareness Week website and signing the ‘Move Away from Muesli’ pledge, before spreading the word amongst fellow rabbit owners. It’s our ambition to move as many rabbits away from muesli towards a good quality hay-based diet supplemented by a small portion of high-quality nuggets and a few fresh greens, which provides the nutrients rabbits need to be happy and healthy."
Burgess says there will also be campaign packs to help support practices in spreading the word, details of which will be available nearer the time.
Dechra Veterinary Products has launched Myorelax, a guaifenesin 100 mg/ml solution for infusion for horses which, the company says, relaxes skeletal muscles within minutes.
Dechra's Equine Brand Manager Emma Jennings said: "Myorelax is indicated for the induction of muscle relaxation and immobilisation, as an adjunct to balanced anaesthesia.
"We're delighted to launch this product, which can be combined with a number of sedatives and anaesthetics including detomidine, ketamine and propofol plus local and volatile anaesthetics.
"Myorelax is a centrally acting muscle relaxant which is effective within a few minutes and does not affect the animal's respiratory muscles at therapeutic doses. It can be used in combination with a sedative and local anaesthetics for short procedures and together with appropriate general anaesthetics for induction and maintenance of muscle relaxation during anaesthesia."
Dechra says that horses are able to stand within 45 minutes after single administration, and the product can be used in a 'triple drip' protocol for total intravenous anaesthesia.
Myorelax is available in 500 ml bottles from veterinary wholesalers.
For further information, visit www.dechra.co.uk
A survey carried out by the company in 20151 found that 46% of dog owners were not aware that dogs can potentially suffer from the condition, despite the fact that it affects an estimated 375,000 dogs in the UK.3
The company says ocular conditions account for around one in ten canine consultations in first opinion practice,2 with KCS affecting around 5% of all dogs3, and up to 20% of predisposed breeds.4
To help raise owner awareness, Bayer will be holding the first veterinary Dry Eye Awareness Month in July.
Because early diagnosis and treatment can have a significant impact on prognosis, the focus of the campaign will be on encouraging pet owners to speak to their veterinary surgeon in the hope of increasing early diagnoses and improving the uptake of regular testing of at-risk breeds.
The campaign will include a dedicated social media element, targeting communities of at-risk breeds by inviting them to pledge their commitment to managing dry eye in their pet. A range of practice materials have also been produced for practices to support the drive in their waiting room.
Hannah Watts, Group Product Manager at Bayer said: "With this significant gap in owner understanding of the significance of KCS in dogs, it was clear that more is needed to be done to encourage owners of at-risk breeds to visit their vet practice for early diagnosis.
"The focus of Dry Eye Awareness Month is to support vets in championing the issue amongst their client base, through a range of educational materials. We hope vets will join us in utilising the month as a platform on which to discuss the prevalence and potential seriousness of the condition if left unmanaged."
Bayer’s research also found how poor understanding of the lifelong nature of the condition is one of the main barriers to owner compliance when managing cases, further highlighting the need for education.5
Chris Dixon, Director at Veterinary Vision Ophthalmic Referrals, said: "KCS cases can present acutely, or with subtle clinical signs that will not be detected from initial observations and require a Schirmer tear test to effectively quantify the reflex tear film production. Unless vets are actively discussing the condition with owners, and performing these tests on a regular basis, it is likely that many dogs could remain undiagnosed."
"In any case where ongoing treatment is required, client education is key in successful disease management. Accurate determination of the cause of the KCS will allow for an appropriate choice of medical therapy. When adjunctive tear replacement therapy is required, many owners will admit to not having the time to administer treatments frequently enough, which should factor into the recommendations we make as practitioners. For example, offering a longer acting product which requires less frequent application.”
You can download the Remend ‘Vision Matters – A Focus on Keratoconjunctivitis Sicca’ educational guide for veterinary surgeons here: www.remend.co.uk/vets-area.
Dry Eye Awareness Month practice display materials can be ordered from your Bayer Territory Manager or email: ahmarketing@bayer.com
As a result of the new partnership, customers of Bought By Many will have access to free video consultations with UK-registered veterinary surgeons via the FirstVet app.
In their blurb, the companies say that: "Many common pet health issues can be treated in the comfort of their own home, meaning owners only need to take their pet to the vet when absolutely necessary. Bought By Many customers can save time, money and potential stress to their pet by using the free FirstVet service. When a referral to a local vet is needed, FirstVet provides detailed notes of the initial consultation to both the owner and the vet."
David Prien, FirstVet’s CEO & co-founder, said: "FirstVet couldn't be more excited to offer our veterinary video consultation service together with Bought By Many in the UK.
"From our first meeting with the Bought By Many team, we knew that our values were aligned. We both share a mission to bring the best that technology has to offer both to pet owners and to the veterinary care process.
"Offering pet owners the chance to speak face-to-face with an experienced veterinarian via a video call is a great way to make sure that all pets are getting the right treatment, as fast as possible, in the right location."
For more information on Bought by Many, visit boughtbymany.com/pet-insurance.
The strike follows a breakdown in negotiations for better pay and conditions earlier in the year.
Valley Vets, which is owned by VetPartners, offered a 7.27% increase to its lowest paid staff, with smaller increases for higher paid staff.
However, the BVU rejected the offer, describing it as a "derisory real terms pay cut".
A postal ballot was held and 94% of members voted for industrial action, with a 93% turnout.
The BVU says it is open to restarting negotiations in the hope that an improved offer will make the strike unnecessary.
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
The urinary products, which are made to provide tailored nutritional solutions for cats and dogs with urinary issues, are available in both wet pouches and dry kibble.
The company simultaneously introduced a new urinary diagnostic tool: the Royal Canin Hematura Detection by Blücare.
The tool is made up of granules which are put in a cat’s litter tray and which turn blue if they detect blood in the urine. Royal Canin says it is a revolutionary diagnostic aid that will be able to prevent feline lower urinary tract disease developing any further.
John O’Connor, Corporate Affairs Director at Royal Canin, said: "We are constantly looking to evolve our offer and provide the very best in nutrition. We have simplified our ranges making it easier to navigate and choose the right product for each cat and dog, created a new premium pack design and developed our best veterinary nutritional solutions.
"It was imperative that we worked very closely with the veterinary community in making this bold transformation so we consulted with vets and vet nurses, in addition to pet owners from across the world."
The Royal College of Veterinary Surgeons has announced the results of the 2011 RCVS and VN Council elections.
Elected to the RCVS Council are:
Not elected are:
For the first time in eight years, all six successful RCVS Council candidates have served on Council before, although one - Sandy Trees - is currently an appointed, rather than an elected, member.
For VN Council, one existing member has been returned and two new members have been elected:
Not elected to VN Council was:
Following rises in previous turnouts, voting figures have dropped markedly this year in both RCVS and VN Councils elections, to 15.9% (3,887 voters) and 7.6% (723 voters) respectively. The previous turnouts were 18.8% (in 2010) and 11.2% (in 2009).
RCVS Registrar Jane Hern said: "It's certainly disappointing that the turnout has dropped so much this year. It's unclear whether this is due to lack of time, lack of awareness, or lack of interest, but perhaps anyone who didn't vote could let us know why, so we can see what we could do to increase participation.
"Nevertheless, my congratulations to all successful candidates, who I look forward to formally welcoming, or welcoming back, onto the Councils at RCVS Day in July, and my commiserations to those who were unsuccessful this time and who I hope won't be discouraged from standing again next year."
This year's chosen charity - the Veterinary Benevolent Fund - will receive a cheque for £922 arising from the College's pledge to donate 20p for each veterinary surgeon and veterinary nurse who cast a vote.